Holen Sie sich die Stockscreener-App
393.24
0.86%
3.35
Vorhandelsmarkt:
394.09
0.85
+0.22%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HCA?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$389.89
Offen:
$389.77
24-Stunden-Volumen:
1.17M
Relative Volume:
0.85
Marktkapitalisierung:
$87.24B
Einnahmen:
$76.39B
Nettoeinkommen (Verlust:
$7.81B
KGV:
13.52
EPS:
29.0772
Netto-Cashflow:
$7.93B
1W Leistung:
+1.41%
1M Leistung:
+6.01%
6M Leistung:
-15.77%
1J Leistung:
+0.95%
1-Tages-Spanne:
$388.01
$394.15
1-Wochen-Bereich:
$384.00
$395.03
52-Wochen-Spanne:
$330.00
$556.52
Hca Healthcare Inc Stock (HCA) Company Profile
Firmenname
Hca Healthcare Inc
Sektor
Branche
Telefon
(615) 344-9551
Adresse
ONE PARK PLZ, NASHVILLE, TN
Compare HCA vs THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCA
Hca Healthcare Inc
|
393.24 | 86.49B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
191.20 | 16.11B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
228.03 | 14.28B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
22.86 | 12.14B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
101.39 | 10.03B | 6.07B | 793.80M | 464.40M | 5.9914 |
Hca Healthcare Inc Stock (HCA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-10-14 | Fortgesetzt | Goldman | Buy |
| 2025-07-28 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-07-16 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-29 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-11-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-11-22 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-09-03 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-04 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-11 | Herabstufung | Goldman | Buy → Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Fortgesetzt | JP Morgan | Neutral |
| 2022-07-06 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-29 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-12-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-24 | Eingeleitet | UBS | Buy |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-13 | Fortgesetzt | Citigroup | Neutral |
| 2021-04-26 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-07-13 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-06 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-07-10 | Hochstufung | Goldman | Neutral → Buy |
| 2019-04-23 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-11-16 | Eingeleitet | UBS | Buy |
| 2018-03-23 | Fortgesetzt | Mizuho | Buy |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2018-01-03 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-12-20 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-11-30 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-11-06 | Bestätigt | Citigroup | Neutral |
| 2017-11-01 | Bestätigt | Mizuho | Buy |
| 2017-07-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-06-28 | Eingeleitet | Argus | Buy |
Alle ansehen
Hca Healthcare Inc Aktie (HCA) Neueste Nachrichten
Can HCA's Gene Therapy Milestone Drive Long-Term Growth? - Yahoo Finance
HCA Healthcare focuses on hospital operations as investors watch US care demand - AD HOC NEWS
HCA Healthcare (HCA) Reports Promising Gene-Editing Therapy Study Results - Insider Monkey
Cantor Fitzgerald reiterates HCA Healthcare stock rating at Overweight - Investing.com
Cantor Fitzgerald reiterates HCA Healthcare stock rating at Overweight By Investing.com - Investing.com Canada
HCA Healthcare (HCA): 12 Best Value Stocks to Buy Right Now - Insider Monkey
VivaScore partners with HCA Healthcare UK to extend the impact of health screening through cutting-edge digital platform - EIN Presswire
HCA Healthcare (HCA) Expands Pediatric Gene Editing Access After Journal Study - Yahoo Finance
HCA Healthcare (HCA) Stock After Recent Slide And DCF Upside Potential - Yahoo Finance
HCA Healthcare outlook holds steady as consensus focuses on margins - AD HOC NEWS
How Removal From Key Russell Growth Indexes Will Impact HCA Healthcare (HCA) Investors - Yahoo Finance
HCA DCF Analysis: Intrinsic Value $765 vs Price $392 - GuruFocus
HCA Healthcare (HCA) Has a Hospital Cash-Flow Engine Bigger Than a Labor-Cost Debate - AlphaStreet
HCA Healthcare Announces New England Journal of Medicine Study Highlighting Advances in CRISPR-based Therapy for Children - BioSpace
HCA Healthcare, Inc.(NYSE: HCA) dropped from Russell 1000 Growth-Defensive Index - marketscreener.com
HCA Announces Positive Results for Gene Editing Therapy in Child - GuruFocus
HCA Healthcare earnings calendar, NYSE-listed stock ahead of July report - AD HOC NEWS
HCA Healthcare announces New England Journal of Medicine study highlighting advances in CRISPR-based therapy for children - HCA Healthcare Today
HCA Healthcare Announces New England Journal of Medicine Study H - GuruFocus
HCA: Promising Gene-Editing Therapy Results for Pediatric Patien - GuruFocus
HCA Healthcare Announces New England Journal of Medicine Study Highlighting Advances in CRISPR-based Therapy for Children – Company Announcement - Financial Times
Index Exit And C-Suite Shift Could Be A Game Changer For HCA Healthcare (HCA) - simplywall.st
HCA Healthcare, Inc.(NYSE: HCA) dropped from Russell 1000 Growth Benchmark - marketscreener.com
HCA Healthcare, Inc.(NYSE: HCA) dropped from Russell 3000E Growth Benchmark - marketscreener.com
HCA Healthcare, Inc.(NYSE: HCA) dropped from Russell Top 200 Growth Benchmark - marketscreener.com
TD Cowen Cuts PT on HCA Healthcare (HCA) But Remains Bullish - Insider Monkey
Metropolis Capital Ltd Reduces Stock Holdings in HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare steadies after April earnings drop, shares track broader hospital peers - Ad-hoc-news.de
Michael Burry Loads Up On HCA Despite 23% YTD Fall — Calls Hospital Operator An ‘Insanely Efficient Compounder' - Stocktwits
Price to sales forward of HCA Healthcare, Inc. – NYSE:HCA - TradingView
Price to earnings forward of HCA Healthcare, Inc. – NYSE:HCA - TradingView
Price to earnings forward of HCA Healthcare Inc – TRADEGATE:2BH - TradingView
Price to book forward of HCA Healthcare Inc – TRADEGATE:2BH - TradingView
Enterprise value to revenue forward of HCA Healthcare, Inc. – NYSE:HCA - TradingView
Enterprise value to EBITDA forward of HCA Healthcare Inc – TRADEGATE:2BH - TradingView
HCA Healthcare Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
The Technical Signals Behind (HCA) That Institutions Follow - Stock Traders Daily
HCA Healthcare guidance tweak and dividend focus, shares steady in a robust sector - Ad-hoc-news.de
HCA Florida Healthcare chief nursing officer discusses various emergency services in area - WEAR-TV
HCA FLORIDA JFK HOSPITAL EARNS STATUTORY TEACHING HOSPITAL DESIGNATION - Florida Hospital News and Healthcare Report
HCA Healthcare sets next earnings date, shares compared with Ensign Group - Ad-hoc-news.de
HCA Healthcare Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh - TradingView
2BH Forecast — Price Target — Prediction for 2027 - TradingView
TD Cowen Maintains HCA Healthcare(HCA.US) With Buy Rating, Maintains Target Price $431 - Moomoo
OP Asset Management Ltd Makes New Investment in HCA Healthcare, Inc. $HCA - MarketBeat
Blue Trust Inc. Sells 4,560 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
89 Middle Tennessee nonprofits awarded $2.1M in grants by HCA Healthcare Foundation - WZTV
DAI ‘Doubles Down’ on Hospice with HCA Healthcare Acquisition - Hospice News
DAI To Acquire 24 Home Health Agencies From HCA, ‘Doubling Down’ On Care In The Home - Home Health Care News
How HCA Stock’s Quiet Compounding Changes The Growth Story - Trefis
HCA Healthcare Foundation supports Hope Lodge® communities serving cancer patients and their caregivers - HCA Healthcare Today
Finanzdaten der Hca Healthcare Inc-Aktie (HCA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):